Aspiriant LLC’s iShares Morningstar Growth ETF ILCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,614
Closed -$376K 345
2025
Q4
$376K Sell
3,614
-86
-2% -$8.98K 0.01% 248
2025
Q3
$386K Buy
+3,700
New +$372K 0.01% 224

Other funds holding ILCG

Aspiriant LLC's ILCG Position: Q1 2026 in Review

Aspiriant LLC sold out of iShares Morningstar Growth ETF (ILCG) in Q1 2026, closing a stake of 3,614 shares — an estimated $376K sold.

Aspiriant LLC first reported a position in ILCG in Q3 2025 and held it in 2 quarters. The position peaked at $386K in Q3 2025. 326 funds tracked by Wall St. Rank hold ILCG as of Q1 2026.

  • Aspiriant LLC reported no remaining iShares Morningstar Growth ETF position as of Q1 2026 after selling out during the quarter.
  • Aspiriant LLC sold 3,614 iShares Morningstar Growth ETF shares in Q1 2026, an estimated $376K.
  • Aspiriant LLC first reported a position in iShares Morningstar Growth ETF in Q3 2025 and held it in 2 quarters.
  • Aspiriant LLC's iShares Morningstar Growth ETF position peaked at $386K in Q3 2025.
  • 326 funds tracked by Wall St. Rank held iShares Morningstar Growth ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.